BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37768027)

  • 21. [Serious adverse events associated with chemotherapy in children with acute lymphoblastic leukemia].
    Xu FL; Guan XM; Wen XH; Shen YL; Xiao JW; Guo YX; Deng MY; Yu J
    Zhongguo Dang Dai Er Ke Za Zhi; 2020 Aug; 22(8):828-833. PubMed ID: 32800028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clotting abnormalities in children during maintenance chemotherapy for acute lymphoblastic leukemia.
    Aricò M; Gamba G; Raiteri E; Montani N; De Amici M; Burgio GR
    Haematologica; 1991; 76(6):472-4. PubMed ID: 1820983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Septicemia after chemotherapy for childhood acute lymphoblastic leukemia in China: A multicenter study CCCG-ALL-2015.
    Zhu Y; Yang R; Cai J; Yu J; Tang Y; Chen Y; Wang N; He H; Wu X; Cheng FWT; Sun L; He Y; Ju X; Tian X; Hu Q; Jin R; Pan K; Fang Y; Zhai X; Jiang H; Li CK
    Cancer Med; 2020 Mar; 9(6):2113-2121. PubMed ID: 31994344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical Characteristic, Diagnosis and Treatment of Acute Lymphoblastic Leukemia Combined with Pneumocystis Carinii Pneumonia in Children].
    Lin SF; Hou LL; Wang J; Xu LH; Liu Y; Mai YG; Fang JP; Zhou DH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Aug; 30(4):1079-1085. PubMed ID: 35981365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group Study L99-15.
    Manabe A; Ohara A; Hasegawa D; Koh K; Saito T; Kiyokawa N; Kikuchi A; Takahashi H; Ikuta K; Hayashi Y; Hanada R; Tsuchida M;
    Haematologica; 2008 Aug; 93(8):1155-60. PubMed ID: 18519521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Leukemia and malnutrition. II. The magnitude of maintenance chemotherapy as a prognostic factor in the survival of patients with standard-risk acute lymphoblastic leukemia].
    Lobato-Mendizábal E; Ruiz-Argüelles GJ
    Rev Invest Clin; 1990; 42(2):81-7. PubMed ID: 2267453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inotuzumab ozogamicin in combination with low-intensity chemotherapy for older patients with Philadelphia chromosome-negative acute lymphoblastic leukaemia: a single-arm, phase 2 study.
    Kantarjian H; Ravandi F; Short NJ; Huang X; Jain N; Sasaki K; Daver N; Pemmaraju N; Khoury JD; Jorgensen J; Alvarado Y; Konopleva M; Garcia-Manero G; Kadia T; Yilmaz M; Bortakhur G; Burger J; Kornblau S; Wierda W; DiNardo C; Ferrajoli A; Jacob J; Garris R; O'Brien S; Jabbour E
    Lancet Oncol; 2018 Feb; 19(2):240-248. PubMed ID: 29352703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Severe anemia due to B19 parvovirus infection in children with acute leukemia in remission.
    Rao SP; Miller ST; Cohen BJ
    Am J Pediatr Hematol Oncol; 1990; 12(2):194-7. PubMed ID: 2165747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical features of children with acute lymphoblastic leukemia complicated by pulmonary infection after chemotherapy].
    Zhang PF; Feng XQ; Wu CL; Zhang YM
    Zhongguo Dang Dai Er Ke Za Zhi; 2017 Dec; 19(12):1234-1238. PubMed ID: 29237521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Infections during induction therapy of childhood acute lymphoblastic leukemia--no association to mannose-binding lectin deficiency.
    Lausen B; Schmiegelow K; Andreassen B; Madsen HO; Garred P
    Eur J Haematol; 2006 Jun; 76(6):481-7. PubMed ID: 16494622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The development of thromboembolism may increase the risk of osteonecrosis in children with acute lymphoblastic leukemia.
    Badhiwala JH; Nayiager T; Athale UH
    Pediatr Blood Cancer; 2015 Oct; 62(10):1851-4. PubMed ID: 25931304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pediatric-Like Acute Lymphoblastic Leukemia Therapy in Adults With Lymphoblastic Lymphoma: The GRAALL-LYSA LL03 Study.
    Lepretre S; Touzart A; Vermeulin T; Picquenot JM; Tanguy-Schmidt A; Salles G; Lamy T; Béné MC; Raffoux E; Huguet F; Chevallier P; Bologna S; Bouabdallah R; Benichou J; Brière J; Moreau A; Tallon-Simon V; Seris S; Graux C; Asnafi V; Ifrah N; Macintyre E; Dombret H
    J Clin Oncol; 2016 Feb; 34(6):572-80. PubMed ID: 26644537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low relapse rate in children with acute lymphoblastic leukemia after risk-directed therapy.
    Tzortzatou-Stathopoulou F; Papadopoulou AL; Moschovi M; Botsonis A; Tsangaris GT
    J Pediatr Hematol Oncol; 2001 Dec; 23(9):591-7. PubMed ID: 11902303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors influencing central line infections in children with acute lymphoblastic leukemia: results of a single institutional study.
    Abbas AA; Fryer CJ; Paltiel C; Chedid F; Felimban SK; Yousef AA; Khattab TM
    Pediatr Blood Cancer; 2004 Apr; 42(4):325-31. PubMed ID: 14966828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early and delayed consolidation chemotherapy significantly improves the outcome of children with intermediate risk acute lymphoblastic leukemia. Final results of the prospective randomized PETHEMA ALL-89 TRIAL.
    Ortega JJ; Ribera JM; Oriol A; Bastida P; González ME; Calvo C; Egurbide I; Hernández Rivas JM; Rivas C; Alcalá A; Besalduch J; Maciá J; Gardella S; Carnero M; Lite JM; Casanova F; Martinez M; Fontanillas M; Feliu E; San Miguel JF;
    Haematologica; 2001 Jun; 86(6):586-95. PubMed ID: 11418367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dexamethasone in the maintenance phase of acute lymphoblastic leukaemia treatment: is the risk of lethal infections too high?
    Te Poele EM; de Bont ES; Marike Boezen H; Revesz T; Bökkerink JP; Beishuizen A; Nijhuis IJ; Oude Nijhuis CS; Veerman AJ; Kamps WA
    Eur J Cancer; 2007 Nov; 43(17):2532-6. PubMed ID: 17702568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative assessment of cerebral atrophy during and after treatment in children with acute lymphoblastic leukemia.
    Prassopoulos P; Cavouras D; Golfinopoulos S; Evlogias N; Theodoropoulos V; Panagiotou J
    Invest Radiol; 1996 Dec; 31(12):749-54. PubMed ID: 8970876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence of skeletal complications during treatment of childhood acute lymphoblastic leukemia: comparison of fracture risk with the General Practice Research Database.
    Högler W; Wehl G; van Staa T; Meister B; Klein-Franke A; Kropshofer G
    Pediatr Blood Cancer; 2007 Jan; 48(1):21-7. PubMed ID: 16317756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Outcome of children with T cell acute lymphoblastic leukemia treated with Chinese Children Leukemia Group acute lymphoblastic leukemia (CCLG-ALL) 2008 protocol].
    Liu XM; Chen XJ; Zou Y; Wang SC; Wang M; Zhang L; Chen YM; Yang WY; Guo Y; Zhu XF
    Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):761-766. PubMed ID: 31594062
    [No Abstract]   [Full Text] [Related]  

  • 40. The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol.
    Güneş AM; Oren H; Baytan B; Bengoa SY; Evim MS; Gözmen S; Tüfekçi O; Karapınar TH; Irken G
    Ann Hematol; 2014 Oct; 93(10):1677-84. PubMed ID: 24863691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.